Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Coopersmith

Allan Coopersmith, Montreal CA

Patent application numberDescriptionPublished
20090274999CUSTOM IMPRESSION COPING AND METHODS OF MANUFACTURE AND USE THEREOF - A device for retracting gingival tissue away from a tooth or plurality of teeth prepared to receive a dental prosthesis comprising a retraction/impression material associated with a custom impression coping to be packed into a sulcus associated with the prepared tooth, and coincidentally obtaining an impression of said tooth or teeth. The device is preferably compressible, deformably rigid, extensile and non-elastic and will not stick to the gingiva or tooth structure thereby allowing for atraumatic removal. A method of use is also disclosed.11-05-2009

Patent applications by Allan Coopersmith, Montreal CA

Robert Coopersmith, Chestnut Hill, MA US

Patent application numberDescriptionPublished
20100130527INDIVIDUALIZED CANCER TREATMENT - Methods to formulate treatments for individual cancer patients by assessing genomic and/or phenotypic differences between cancer and normal tissues and integrating the results to identify dysfunctional pathways are described.05-27-2010

Robert Mark Coopersmith, Chestnut Hill, MA US

Patent application numberDescriptionPublished
20080234345METHOD FOR REDUCING OR ALLEVIATING INFLAMMATION IN THE DIGESTIVE TRACT - A method is provided for reducing or alleviating inflammation or a pathological process associated therewith or secondary thereto in a subject having an inflammatory disease of the digestive tract. The method comprises administering to the subject an anti-inflammatorily effective amount of an ACE2 inhibitor.09-25-2008
20090186014METHOD FOR TREATMENT OF PANCREATITIS - A method for treating acute or chronic pancreatitis in a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor.07-23-2009
20090192220TREATMENT FOR SOLID TUMORS - A method for treating a solid tumor in a subject comprises administering to the subject an ACAT inhibitory compound or a prodrug thereof, for example avasimibe, wherein (a) the solid tumor is at least about 2 mm in diameter and (b) the compound or prodrug thereof is administered in an amount that is therapeutically effective, but ineffective to cause unacceptable toxicity to normoxic tissues.07-30-2009
20100029734METHODS FOR BREAST CANCER SCREENING AND TREATMENT - A method for selecting a breast cancer patient for therapy with an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, comprises (a) determining whether the cancer comprises a tumor that is estrogen receptor positive (ER+) and (b) selecting the patient for such therapy only if the cancer is determined to comprise an ER+ tumor. A method for treating breast cancer in a patient further comprises (c) administering to the patient, if so selected, an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A method for treating a breast tumor in a patient having SERM-resistant ER+ breast cancer comprises administering to the patient an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor. A therapeutic combination useful in treatment of a breast tumor comprises an agent that reduces production of angiotensin II, for example an ACE inhibitor or renin inhibitor, and a second agent that comprises (a) an aromatase inhibitor or (b) an estrogen receptor modulator or antagonist.02-04-2010
20100035848THERAPY FOR DISORDERS OF THE PROXIMAL DIGESTIVE TRACT - A method for managing or treating an inflammatory, erosive, dyspeptic or reflux disorder of the proximal digestive tract of a subject comprises administering to the subject a therapeutically effective amount of an ACE2 inhibitor. A therapeutic combination, useful to treat any disease or condition in which an NSAID is indicated, comprises an NSAID in an anti-inflammatory, analgesic or antipyretic effective amount and a gastroprotective agent that comprises an ACE2 inhibitor in an amount effective to protect mucosal surfaces of the proximal digestive tract from erosion or ulceration induced by the NSAID.02-11-2010

Patent applications by Robert Mark Coopersmith, Chestnut Hill, MA US

Robert Mark Coopersmith, Norfolk County, MA US

Patent application numberDescriptionPublished
20090012052METHOD FOR TREATING ER+ BREAST CANCER - A method for selecting a female breast cancer patient for AT01-08-2009